Cited by 787Schizophrenia research and treatmentMental Health and PsychiatryBipolar Disorder and Treatment

The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.

Neuroleptics and the Natural Course of Schizophrenia

Wyatt, R. J.·1991·Schizophrenia Bulletin

Open this paper in CoChat — free account

Abstract

To determine if neuroleptic treatment changes the natural course of schizophrenia, 22 studies were reviewed in which relatively similar patients were or were not given neuroleptics at specific times during the course of their illness. Nineteen of the studies were from first- or predominantly first-break populations. While there was little consensus among the authors of the studies reviewed, a reanalysis of the data indicates that early intervention with neuroleptics in first-break schizophrenic patients increases the likelihood of an improved long-term course. This finding is similar to that of earlier investigators who indicated there was a decrease in patients with the more severe forms of the illness following the introduction of convulsive therapies. Furthermore, there is evidence that stable schizophrenic patients whose neuroleptics are discontinued and have relapses may have a difficult time returning to their previous level of function. The findings describe in this paper have implications for both the treatment of schizophrenia and for understanding the pathophysiological processes that determine the course of the disorder.

Integrity signals

Registry

Crossref · 10.1093/schbul/17.2.325

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Statistical principles in experimental design.
Winer, B. J. (1962) · McGraw-Hill Book Company · doi:10.1037/11774-000 · Cited by 27,137
Dementia Praecox or the Group of Schizophrenias
(1951) · Journal of the American Medical Association · doi:10.1001/jama.1951.02920270079043 · Cited by 4,407
Dementia Praecox and Paraphrenia.
(1972) · Annals of Internal Medicine · doi:10.7326/0003-4819-76-6-1058_8 · Cited by 2,907
Statistical Methods for Survival Data Analysis.
Lachenbruch, P. A., & Lee, E. T. (1993) · Journal of the American Statistical Association · doi:10.2307/2290742 · Cited by 2,851
International Classification of Diseases, 10th Revision
Tassé, M. J., & Bush, K. (2018) · Sage eBooks · doi:10.4135/9781483392271.n276 · Cited by 1,921
Drug and Family Therapy in the Aftercare of Acute Schizophrenics
Goldstein, M. J. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770340019001 · Cited by 521
II. A Randomised Controlled Trial of Prophylactic Neuroleptic Treatment
Crow, T. J., Macmillan, J. F., Johnson, A. L., & Johnstone, E. C. (1986) · The British Journal of Psychiatry · doi:10.1192/bjp.148.2.120 · Cited by 491
Schizophrenia, just the facts
Wyatt, R. J., Alexander, R., Egan, M. F., & Kirch, D. G. (1988) · Schizophrenia Research · doi:10.1016/0920-9964(88)90034-5 · Cited by 478
Self-citation
Neuropathology of Schizophrenia
Stevens, J. R. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290100011003 · Cited by 474
Longitudinal Studies of Schizophrenic Patients
Huber, G., Gross, G., Schüttler, R., Linz, M. H., & Clemens, S. L. (1980) · Schizophrenia Bulletin · doi:10.1093/schbul/6.4.592 · Cited by 439

Show all 73 references

Sorted by citations

Items 501–600 of 787

Medisinfrie sykehusposter – et kunnskapsløst tiltak
Røssberg, J. I., Andreassen, O. A., & Ilner, S. O. (2017) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.17.0091 · Cited by 9
Phase prodromale du trouble bipolaire
Fakra, É., Kaladjian, A., Fonséca, D. D., Maurel, M., Adida, M., Besnier, N., Pringuey, D., & Azorin, J. (2010) · L Encéphale · doi:10.1016/s0013-7006(10)70003-8 · Cited by 9
Antipsychotic Medication Nonadherence: Risk Factors and Remedies
Freudenreich, O., & Cather, C. (2012) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.10.2.124 · Cited by 9
Drug-Resistant Schizophrenia
Jalenques, I. (1996) · CNS Drugs · doi:10.2165/00023210-199605010-00002 · Cited by 9
Clozapine as a treatment tool: only in resistant schizophrenic patients?
Cassano, G., Ciapparelli, A., & Villa, M. A. (1997) · European Psychiatry · doi:10.1016/s0924-9338(97)83578-x · Cited by 9
Neuroplasticity and Psychiatry
Gynther, B., Calford, M. B., & Sah, P. (1998) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048679809062718 · Cited by 9
Asymmetry of RCBF in Schizophrenia: Relationship to AP-gradient and duration of illness
Wilson, W. H., & Mathew, R. J. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90022-6 · Cited by 9
Tardive Dyskinesia
Hyde, T. M., Apud, J. A., Fisher, W. C., & Egan, M. F. (2005) · doi:10.1002/9780470753217.ch9 · Cited by 9
FIRST EPISODE PSYCHOSIS: EARLY INTERVENTION STRATEGIES WITH SECOND‐GENERATION ANTIPSYCHOTIC MEDICATIONS
Bryden, K., Gardner, D., & Kopala, L. (2003) · International journal of clinical practice · doi:10.1111/j.1742-1241.2003.tb10542.x · Cited by 10
Helping people to discontinue antipsychotics: if, when and how
Moncrieff, J., & Horowitz, M. A. (2025) · Schizophrenia · doi:10.1038/s41537-025-00695-x · Cited by 9
Impact de la durée de psychose non traitée sur la qualité de vie et les fonctions cognitives
Rebhi, H., Damak, R., Chérif, W., Ellini, S., Cheour, M., & Ellouze, F. (2018) · L Encéphale · doi:10.1016/j.encep.2017.12.006 · Cited by 8
Déficit atencionales y respuesta al tratamiento farmacológico en pacientes con esquizofrenia resistente al tratamiento: Resultados mediante análisis factorial confirmatorio
Sánchez, P., Ojeda, N., Elizagárate, E., Peña, J., Ballesteros, J., Yoller, A. B., Gutiérrez, M., Casais, L., & Ezcurra, J. (2010) · Revista de Psiquiatría y Salud Mental · doi:10.1016/j.rpsm.2010.02.001 · Cited by 8
Early Recognition and Intervention
Johannessen, J. O. (2001) · Disease Management & Health Outcomes · doi:10.2165/00115677-200109060-00003 · Cited by 8
Beyond the first episode: Candidate factors for a risk prediction model of schizophrenia
Murphy, B. (2010) · International Review of Psychiatry · doi:10.3109/09540261003661833 · Cited by 7
Noncompliance and its Causes Resulting in Psychiatric Readmissions
Yaghoubi, M., Mohsen, Y., Omranifard, V., & Namdari, M. (2008) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 8
Mental Health Legislation and the Right to Appropriate Treatment
O’Reilly, R. L. (1998) · The Canadian Journal of Psychiatry · doi:10.1177/070674379804300805 · Cited by 9
Disease modifying effects of antipsychotic drugs in schizophrenia: a clinical and neurobiological perspective
Lieberman, J. A. (2018) · World Psychiatry · doi:10.1002/wps.20543 · Cited by 8
Cognitive deficits in schizophrenia: early course and treatment
Harvey, P. D., & Bowie, C. R. (2003) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(03)00015-x · Cited by 8
The role of the general practitioner in the treatment of schizophrenia: general principles
Carr, V. J. (1997) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1997.tb138732.x · Cited by 8
The Timing of Neurodevelopmental Abnormality in Schizophrenia: An Integrative Review of the Neuroimaging Literature
Lencz, T., Bilder, R. M., & Cornblatt, B. A. (2001) · CNS Spectrums · doi:10.1017/s1092852900008610 · Cited by 8
Outcome studies in schizophrenia
Browne, S., Larkin, C., & O’Callaghan, E. (1999) · Irish Journal of Psychological Medicine · doi:10.1017/s0790966700005528 · Cited by 8
Long-term adaptive life functioning in relation to initiation of treatment with antipsychotics over the lifetime trajectory of schizophrenia
Quinn, J. F., Moran, M., Lane, A., Kinsella, A., & Waddington, J. L. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00248-1 · Cited by 8
Schizophrenia, Genetic Retrenchment, and Epidemiologic Renaissance
Waddington, J. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820120078011 · Cited by 8
Schizophrenia and Related Psychoses
(2021) · Wiley eBooks · doi:10.1002/9781119870203.mpg001 · Cited by 9
Pathways to care and reducing treatment delay in early psychosis
Norman, R. M. G., & MALLA, A. K. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511576287.011 · Cited by 7
[Impact of the duration of untreated psychosis among patients with a first episode: a one year follow-up study].
Apiquián, R., Fresán, A., García‐Anaya, M., Lóyzaga-Mendoza, C., & Nicolini, H. (2006) · PubMed · Cited by 7
The Tips Project
Johannessen, J. O., Larsen, T. K., Horneland, M., Joa, I., Mardal, S., Kvebæk, R., Friis, S., Melle, I. S., Opjordsmoen, S., Simonsen, E. H., et al. (2001) · Springer eBooks · doi:10.1007/978-94-010-0892-1_8 · Cited by 7
The Prevalence and Associated Factors of Psychiatric Early Readmission in a Teaching Hospital, Malaysia
Cg, N., Hs, L., Ha, Y., & Nz, Z. (2012) · The Malaysian journal of psychiatry · Cited by 7
The promises and challenges of early intervention in psychotic disorders
MALLA, A. K. (2008) · World Psychiatry · doi:10.1002/j.2051-5545.2008.tb00183.x · Cited by 7
Treatment Outcome in Patients With Chronic Schizophrenia During Long-term Administration With Risperidone
Reveley, M. A., & Libretto, S. E. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000126661.58411.d3 · Cited by 7
Kraepelin's dichotomy is true: contrasting brain dysfunction at the extremes of human growth and maturation. Excitability, the fundamental property of nervous tissue, is affected
Saugstad, L. F. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701405821 · Cited by 7
Barriers to care in severe mental illness: accounts from perpetrators of intra-familial homicide
Stanton, J., & Skipworth, J. (2005) · Criminal Behaviour and Mental Health · doi:10.1002/cbm.3 · Cited by 7
The association between relapse and the outcome of schizophrenia and recurrent psychotic disorders
Moncrieff, J., Pillai, E., Marston, L., Lewis, G., Barnes, T. R. E., Johnson, S., & Priebe, S. (2025) · The British Journal of Psychiatry · doi:10.1192/bjp.2024.304 · Cited by 8
Application of Interpersonal and Social Rhythm Therapy (IPSRT) for Depression Associated With Schizophrenia Spectrum Disorders
Bonfils, K. A., & Novick, D. M. (2021) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.20200024 · Cited by 6
Clinical Staging in Schizophrenia Spectrum Disorders
Dombi, Z. B., Barabássy, Á., Sebe, B., Laszlovszky, I., & Németh, G. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98276 · Cited by 6
Intervention précoce pour les premiers épisodes psychotiques d’hier à demain : comment relever les défis liés à son déploiement pour en maximiser les bénéfices ?
MALLA, A. K., Roy, M., Abdel‐Baki, A., Conus, P., & McGorry, P. D. (2021) · Santé mentale au Québec · doi:10.7202/1088190ar · Cited by 6
Defining and characterising treatment-resistant schizophrenia
Marder, S. R. (1995) · European Psychiatry · doi:10.1016/0767-399x(96)80078-2 · Cited by 6
Disability Reduction in Elderly Patients with Schizophrenia
Schimming, C., & Harvey, P. D. (2004) · Journal of Psychiatric Practice · doi:10.1097/00131746-200409000-00002 · Cited by 6
Boredom, dopamine, and the thrill of psychosis: psychiatry in a new key.
Branković, S. (2015) · PubMed · Cited by 7
Cognitive function in early psychosis patients from a lower middle-income country
Husain, M. O., Chaudhry, I. B., Thomasson, R., Kiran, T., Bassett, P., Husain, M. I., Naeem, F., & Husain, N. (2017) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2017.1341987 · Cited by 6
Integrating Religion and Spirituality into Clinical Practice
Hefti, R., & Büssing, A. (2018) · MDPI eBooks · doi:10.3390/books978-3-03842-929-6 · Cited by 6
The Weaknesses of the Strengths Model
Taylor, E. H. (2006) · Best practices in mental health · doi:10.70256/844628vnanjw · Cited by 6
Persistent psychosis after reduction in pre- and post-synaptic dopaminergic function
Wolkin, A., Duncan, E., Sanfilipo, M. P., Wieland, S., Cooper, T. B., & Rotrosen, J. (1994) · Journal of Neural Transmission · doi:10.1007/bf01283030 · Cited by 6
Disease Models of Mental Illness and Aftercare Patient Education: Critical Observations from Meta-Analyses, Cross-Cultural Practice and Anthropological Study
McGruder, J. (2004) · British Journal of Occupational Therapy · doi:10.1177/030802260406700705 · Cited by 6
Psychopathology and Neuropsychological Assessment
Sweet, J. J., & Westergaard, C. (1997) · Critical issues in neuropsychology · doi:10.1007/978-1-4757-9820-3_10 · Cited by 6
Prodromal Schizophrenia and Atypical Antipsychotic Treatment
Kablinger, A. S., & Freeman, A. M. (2000) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-200010000-00002 · Cited by 6
Cannabis use and abstention in first-episode psychosis: the participants'view
Seddon, J. L., Copello, A. G., & Birchwood, M. J. (2013) · Mental Health and Substance Use · doi:10.1080/17523281.2012.660190 · Cited by 6
Psychosocial Acute Treatment in Early-Episode Schizophrenia Disorders
Bola, J. R. (2006) · Research on Social Work Practice · doi:10.1177/1049731505284447 · Cited by 6
Encouraging Pursuit of Court-Ordered Treatment in a State Hospital
Patel, M., & Hardy, D. W. (2001) · Psychiatric Services · doi:10.1176/appi.ps.52.12.1656 · Cited by 6
Psychiatry's Remarkable Journey: The Past 40 Years
Pardes, H. (2003) · Psychiatric Services · doi:10.1176/appi.ps.54.6.896 · Cited by 6
Clozapine response in early treatment-resistant schizophrenia
Joffe, G., Rybak, J., Burkin, M. M., Burkin, D., Appelberg, B., Joffe, M., Gädeke, R., & Rimón, R. (1997) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651509709024737 · Cited by 6
Early Intervention in Psychosis Guidance Note
Disley, B. (1998) · Cited by 6
Schizophrenia
Bartels, S. J., Mueser, K. T., & Miles, K. M. (1998) · Springer eBooks · doi:10.1007/978-1-4899-0130-9_9 · Cited by 6
Early intervention and sustaining the management of vulnerability
Birchwood, M. J. (2000) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2000.00791.x · Cited by 6
Clozapine and Risperidone: Refining and Extending Their Use
Buckley, P. F., & Schulz, C. S. (1996) · Harvard Review of Psychiatry · doi:10.3109/10673229609030543 · Cited by 6
Schizophrénie, approche spécialisée et continuité de soins. Le programme spécifique d’intervention Premier-Épisode de l’Hôtel-Dieu de Lévis
Nicole, L., Pires, A. D. S., Routhier, G., Bélanger, R., Bussière, G., L’Heureux, S., Gingras, N., Rivard, P., Chabot, P., Descombes, J. P., et al. (2006) · Santé mentale au Québec · doi:10.7202/031588ar · Cited by 6
Disfunções cognitivas em sujeitos portadores de esquizofrenia no Brasil: amplitude, gravidade e relação com a demora no acesso ao tratamento médico
Ayres, A. M. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2009.tde-27082009-154755 · Cited by 6
Predictors of outcome in schizophrenia: the concept of time
Lieberman, J. A. (1994) · Springer eBooks · doi:10.1007/978-3-7091-6636-9_5 · Cited by 6
Risperidone, Haloperidol and Clozapine in the South Carolina Medicaid Program
Shermock, K. M., Sadik, M. K., Kozma, C. M., Sesti, A.-M., & Reeder, C. E. (2001) · Disease Management & Health Outcomes · doi:10.2165/00115677-200109040-00003 · Cited by 6
Entire duration of active psychosis and neurocognitive performance in first‐episode non‐affective psychosis
Murillo‐García, N., Setién‐Suero, E., de Santayana, G. P., Murillo‐García, M., Pelayo‐Terán, J. M., Crespo‐Facorro, B., & Ayesa‐Arriola, R. (2020) · Early Intervention in Psychiatry · doi:10.1111/eip.13077 · Cited by 5
Intervening Early in Psychosis: A Team Approach
(2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379217 · Cited by 5
Assessment of Therapy-Resistant Schizophrenia
Lindenmayer, J., & Khan, A. (2010) · Advances in biological psychiatry · doi:10.1159/000319806 · Cited by 5
Beliefs about antipsychotic versus hypoglycemic medications among individuals with serious mental illness and type 2 diabetes
Aakre, J. M., Medoff, D. R., Dixon, L. B., & Kreyenbuhl, J. A. (2012) · Patient Preference and Adherence · doi:10.2147/ppa.s30975 · Cited by 5
Early detection of schizophrenia
Klosterkötter, J. (2011) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2011.02.001 · Cited by 5
Attention Deficits and Response to Drug Therapy in Patients With Treatment-Resistant Schizophrenia: Results Through Confirmatory Factorial Analysis
Sánchez, P., Ojeda, N., Elizagárate, E., Peña, J., Ballesteros, J., Yoller, A. B., Gutiérrez, M., Casais, L., & Ezcurra, J. (2010) · Revista de Psiquiatría y Salud Mental (English Edition) · doi:10.1016/s2173-5050(10)70008-x · Cited by 5
Concept and Management of Treatment Resistant Schizophrenia (TRS).
Painuly, N., Gupta, N., & Avasthi, A. (2004) · PubMed Central · Cited by 5
Factors Predicting Personal and Social Performance in Schizophrenia Patients
Chi, S., Jeong, H., Lee, M., & Kim, S. (2016) · Korean Journal of Schizophrenia Research · doi:10.16946/kjsr.2016.19.2.47 · Cited by 5
Kognitive Störungen und Elektrokrampftherapie
Prapotnik, M., Pycha, R., Nemes, C., König, P., Hausmann, A., & Conca, A. (2006) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-005-0237-6 · Cited by 5
Recency and intensification of positive symptoms enhance prediction of conversion to syndromal psychosis in clinical high-risk patients
Brucato, G., First, M. B., Dishy, G. A., Samuel, S. S., Xu, Q., Wall, M. M., Small, S. A., Masucci, M. D., Lieberman, J. A., & Girgis, R. R. (2019) · Psychological Medicine · doi:10.1017/s0033291719003040 · Cited by 5
Suizidalität bei schizophrenen Psychosen: eine aktuelle Übersicht
Knorr, R., & Hoffmann, K. K. P. (2020) · Der Nervenarzt · doi:10.1007/s00115-020-01028-2 · Cited by 6
Cortical changes in patients with schizophrenia across two ethnic backgrounds
Langenbach, B. P., Kohl, W., Murai, T., Suslow, T., Ohrmann, P., Bauer, J., Matsukawa, N., Son, S., Pedersen, A., Lichtenstein, T., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-14914-3 · Cited by 5
Détection et intervention précoce pour la psychose : pourquoi et comment ?
Bertulies‐Esposito, B., Sicotte, R., Iyer, S. N., Delfosse, C., Girard, N., Nolin, M., Villeneuve, M., Conus, P., & Abdel‐Baki, A. (2021) · Santé mentale au Québec · doi:10.7202/1088178ar · Cited by 7
Lack of progressive reduction in P3 amplitude after the first–episode of schizophrenia: A 6-year follow-up study
Devrim‐Üçok, M., Keskin-Ergen, Y., & Üçok, A. (2016) · Psychiatry Research · doi:10.1016/j.psychres.2016.02.065 · Cited by 5
Treatment of schizophrenia: An update I. The vulnerability-stress model and biologic treatment modalities
Bentsen, H. (1993) · Nordic Journal of Psychiatry · doi:10.3109/08039489309103332 · Cited by 5
Electroconvulsive Therapy in a Child Suffering from Acute and Transient Psychotic Disorder with Catatonic Features
Mohapatra, S., & Rath, N. (2015) · Indian Journal of Psychological Medicine · doi:10.4103/0253-7176.168603 · Cited by 5
Benefits of Boarding Home Placement in Patients with Schizophrenia
Bota, R. G., Munro, J. S., & Sagduyu, K. (2007) · Southern Medical Journal · doi:10.1097/01.smj.0000254188.27513.34 · Cited by 5
Involuntary psychiatric interventions: a breach of the Hippocratic oath?
Stastny, P. (2000) · PubMed · Cited by 5
From first to second generation antipsychotics
Waddington, J. L., & Quinn, J. F. (2000) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8448-8_2 · Cited by 5
De (in)effectiviteit van psychofarmaca
van den Burg, W. (1998) · Directieve therapie · doi:10.1007/bf03060189 · Cited by 5
Duration of untreated illness in psychosis: conceptualising duration of the psychosis prodrome and duration of untreated psychosis in predicting outcome and refining early intervention
Waddington, J. L., Nkire, N., Kinsella, A., Russell, V., & Clarke, M. (2025) · Psychiatry Research Communications · doi:10.1016/j.psycom.2025.100232 · Cited by 4
Clinical Implications of the Drug-Centered Approach
Steingard, S. (2018) · Springer eBooks · doi:10.1007/978-3-030-02732-2_5 · Cited by 4
Duration of untreated psychosis and cognitive function in first-episode antipsychotic-naïve schizophrenia: Evidence from auditory P300
Lu, C., Li, S., Liu, N., Li, T., Li, Y., Wang, X., Li, S., Li, J., & Zhang, X. Y. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111202 · Cited by 4
Relation Between Clinical and Social Variables and Duration of Untreated Psychosis in First Episode Psychosis
Kini, G., Tharayil, H. M., Prabhavathy, K. S., & Haridas, N. J. (2015) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.30834/kjp.28.2.2015.32 · Cited by 4
Liste d'évaluation pour le dépistage précoce de la schizophrénie au cabinet du généraliste
Aston, J., Gschandtner, U., & Riecher‐Rössler, A. (2002) · Forum Médical Suisse ‒ Swiss Medical Forum · doi:10.4414/fms.2002.04661 · Cited by 4
Neurodegenerative models of schizophrenia
Jarskog, L. F., Gilmore, J. H., & Lieberman, J. A. (2004) · Cambridge University Press eBooks · doi:10.1017/cbo9780511735103.022 · Cited by 4
Early intervention services for psychosis in the metaphorical ‘trenches’ of contemporary care: Already known from the real trenches of WW1?
Waddington, J. L. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.06.021 · Cited by 4
New Targets for the Management of Schizophrenia
Dılbaz, N., & CONTINUUM Treatment Group (2015) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20151125024949 · Cited by 6
Early intervention in psychosis: service models worldwide and the Irish experience
Omer, S., Behan, C., Waddington, J., & O'Callaghan, E. (2010) · Irish Journal of Psychological Medicine · doi:10.1017/s0790966700001555 · Cited by 4
ELECTRO CONVULSIVE THERAPY IN PRE-PUBERTAL CATATONIA: A CASE STUDY
Thakur, A., Dutta, S., Jagadheesan, K., & SINHA, V. K. (2001) · Indian Journal of Psychiatry · doi:10.4103/ijopsy_2001434_354 · Cited by 4
Low-dose neuroleptic therapy and extrapyramidal side effects in schizophrenia: An effect size analysis
Barbui, C., & Saraceno, B. (1996) · European Psychiatry · doi:10.1016/s0924-9338(97)82580-1 · Cited by 4
Use of risperidone long-acting injectable in a rural border community clinic in southern california.
Camacho, A., Ng, B., Galangue, B., & Feifel, D. (2008) · PubMed Central · Cited by 4
Early Detection and Intervention Through Integration With Primary Health Services: The Buckingham Project
Falloon, I. R. H. (2001) · Springer eBooks · doi:10.1007/978-94-010-0892-1_6 · Cited by 4
Drug Treatment of Patients with Schizophrenia
Fleischhacker, W. W. (2001) · Springer eBooks · doi:10.1007/978-3-642-59519-6_95 · Cited by 4
Predictors of Service Use and Social Conditions in Patients with Psychotic Disorders
MALLA, A. K., Norman, R. M. G., & Scholten, D. J. (2000) · The Canadian Journal of Psychiatry · doi:10.1177/070674370004500306 · Cited by 4
Pharmakotherapie schizophrener Störungen
Fleischhacker, W. W. (2000) · Springer eBooks · doi:10.1007/978-3-642-59626-1_11 · Cited by 4
Response to Commentaries and to the Challenge of Building a Perfect Theory to Explain Schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240037008 · Cited by 4
The Psychobiology of First-Episode Schizophrenia
Waring, E. M. (1995) · The Canadian Journal of Psychiatry · doi:10.1177/070674379504007s02 · Cited by 4
Behavioral variant frontotemporal dementia in patients with previous severe mental illness: a systematic and critical review
Gambogi, L. B., Guimarães, H. C., de Souza, L. C., & Caramelli, P. (2019) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20190107 · Cited by 3
Case Report: Successful Implementation of Integrative Cognitive Remediation for Early Psychosis
Vidarsdottir, O. G., Roberts, D. L., Twamley, E. W., Guðmundsdóttir, B., Sigurðsson, E., & Magnúsdóttir, B. B. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.624091 · Cited by 3
Antipsychotic treatment and adherence in schizophrenia
Correll, C. U., Abbott, C., Keith, S. J., & Haddad, P. M. (2016) · Oxford University Press eBooks · doi:10.1093/med/9780198729471.003.0001 · Cited by 3

Authors: Wyatt, R. J.
Affiliations: St. Elizabeths Hospital (US)
Corresponding author: Wyatt, R. J.
Venue: Schizophrenia Bulletin
Publisher: Oxford University Press (OUP)
Published: 1991-01-01
Volume: 17
Issue: 2
Pages: 325-351
ISSN: 0586-7614 (ISSN-L)
1745-1701
DOI: 10.1093/schbul/17.2.325
OpenAlex: W2120012268
Cited by: 787
References: 73
Citations by year: 2026: 6 · 2025: 10 · 2024: 8 · 2023: 5 · 2022: 4 · 2021: 21 · 2020: 12 · 2019: 48 · 2018: 14 · 2017: 18 · 2016: 17 · 2015: 17 · 2014: 18 · 2013: 22 · 2012: 27
FWCI: 13.18
Type: journal article
Language: en
Open access: closed
Locations: Schizophrenia Bulletin (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
Keywords: schizophrenia, antipsychotic drugs
MeSH terms: Humans, Recurrence, Schizophrenia, Time Factors, Antipsychotic Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Neuroleptics and the Natural Course of Schizophrenia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks